The pooled effect size for AD in relation to obesity and diabetes was calculated at 1.59 and 1.54 in longitudinal epidemiological studies of body mass, metabolic syndrome (dyslipidemia, hypertension, abdominal obesity, and insulin resistance), diabetes, and glucose and insulin levels [2]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.